PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
07-Feb-2024 Prevencio and Emory Winship Cancer Institute AI-driven HART CVE Test Data Predicts Risk of Adverse Cardiovascular Effects Associated with Prostate Cancer Therapy Businesswire
07-Feb-2024 QuantHealth Appoints Dr. Adam Petrich, MD, As Its First Chief Medical Officer and Adam Goldberger As First Chief Financial Officer Businesswire
07-Feb-2024 Tris Pharma Appoints Michael Magee as Vice President, Quality & Compliance Businesswire
07-Feb-2024 Qualus Acquires Enkompass Power and Energy, Expanding its Footprint into Canada Businesswire
07-Feb-2024 MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer Businesswire
07-Feb-2024 Cencora Releases 2023 ESG Report Businesswire
07-Feb-2024 VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer Businesswire
07-Feb-2024 Dragos Announces Rick Kramer as Chief Revenue Officer and Angela Crossman as First Chief People Officer Businesswire
07-Feb-2024 Teva Canada classée numéro 1 au tableau des employeurs canadiens de l’industrie pharmaceutique et biotechnologique de Forbes Businesswire
07-Feb-2024 Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology Industry Businesswire
07-Feb-2024 Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program Businesswire
07-Feb-2024 Virpax Pharmaceuticals Announces Preliminary Results of ProbudurTM Pilot Study with the U.S. Army Institute of Surgical Research Businesswire
07-Feb-2024 Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience Businesswire
07-Feb-2024 Myrobalan Therapeutics Receives a Grant from the ALS Association to Advance its CSF1R Inhibitor Program Businesswire
07-Feb-2024 Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference Businesswire
07-Feb-2024 Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Neoadjuvant Opdivo (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo in Resectable Non-Small Cell Lung Cancer Businesswire
07-Feb-2024 Global Flexible Industrial Packaging Market Outlook 2023-2036: Plastic Material Dominates, Rising Demand for Sustainable Packaging Driving Growth - ResearchAndMarkets.com Businesswire
07-Feb-2024 Delta-Fly Pharma Inc.: Abstracts submission for Phase I Clinical Trial of DFP-14927 to 2024 ASCO annual meeting Businesswire
07-Feb-2024 ATS Reports Third Quarter Fiscal 2024 Results Businesswire
07-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire